COVID-19: Perspectives from a Clinical Doctor and Health Authority Officer
Abstract
No Abstract
1. National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine (2020). The diagnosis and treatment protocol for coronavirus disease of China (the seventh edition). http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef 80dc7f5912eb1989.shtml
2. National Administration of Traditional Chinese Medicine (2020). The treatment for COVID-19 with Qing-fei-pai-du-tang. http://www.satcm.gov.cn/hudongjiaoliu/guanfangweixin/2020-02-23/13310. html
3. World Health Organization (2004). Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine World Health Organization. http://apps.who.int/medicinedocs/es/d/Js6170e/
4. Chen W, Lim CE, Kang HJ, Liu J (2011). Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials. PLoS One, 6:e28093.
5. Stockman LJ, Bellamy R, Garner P (2006). SARS: systematic review of treatment effects. PLoS Med. 3:e343.
6. CNR news (2020). Zhong Nanshan: to improve the status of CDC in China. http://www.cnr.cn/gd/ygsy/20200227/t20200227_524994057.shtml
2. National Administration of Traditional Chinese Medicine (2020). The treatment for COVID-19 with Qing-fei-pai-du-tang. http://www.satcm.gov.cn/hudongjiaoliu/guanfangweixin/2020-02-23/13310. html
3. World Health Organization (2004). Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine World Health Organization. http://apps.who.int/medicinedocs/es/d/Js6170e/
4. Chen W, Lim CE, Kang HJ, Liu J (2011). Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials. PLoS One, 6:e28093.
5. Stockman LJ, Bellamy R, Garner P (2006). SARS: systematic review of treatment effects. PLoS Med. 3:e343.
6. CNR news (2020). Zhong Nanshan: to improve the status of CDC in China. http://www.cnr.cn/gd/ygsy/20200227/t20200227_524994057.shtml
| Files | ||
| Issue | Vol 49 No Supple 1 (2020) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v49iS1.3684 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
YU Y-L, FENG W-L. COVID-19: Perspectives from a Clinical Doctor and Health Authority Officer. Iran J Public Health. 2020;49(Supple 1):127-129.
